Aristotle Atlantic Partners, LLC Becton Dickinson & CO Transaction History

Aristotle Atlantic Partners, LLC

$3.19 Billion
Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 83,087 shares of BDX stock, worth $18.7 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

83,087

Previous 80,505 3.21%

Holding current value

$18.7 Million

Previous $18.8 Million 6.47%

% of portfolio

0.63%

Previous 0.61%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $571,835 - $625,902	2,582 Added 3.21%	83,087 $20 Million
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $2.63 Million - $2.88 Million	-11,696 Reduced 12.69%	80,505 $18.8 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $8.37 Million - $8.88 Million	-35,854 Reduced 28.0%	92,201 $22.8 Million
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $8,128 - $9,353	35 Added 0.03%	128,055 $31.2 Million
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $870,228 - $968,176	-3,414 Reduced 2.6%	128,020 $33.1 Million
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $8.87 Million - $9.87 Million	37,219 Added 39.5%	131,434 $34.7 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $2.09 Million - $2.36 Million	9,110 Added 10.7%	94,215 $23.3 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $649,194 - $764,050	2,974 Added 3.62%	85,105 $21.6 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $2.37 Million - $12.3 Million	46,470 Added 130.31%	82,131 $18.3 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $4.14 Million - $4.85 Million	17,619 Added 97.66%	35,661 $8.79 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $230,727 - $256,144	947 Added 5.54%	18,042 $4.8 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $567,377 - $618,818	2,466 Added 16.86%	17,095 $4.3 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $1.31 Million - $1.45 Million	-5,645 Reduced 27.84%	14,629 $3.6 Million
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $286,624 - $313,642	1,232 Added 6.47%	20,274 $4.93 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $429,598 - $475,484	1,851 Added 10.77%	19,042 $4.63 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $389,247 - $431,378	1,754 Added 11.36%	17,191 $4.3 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $871,926 - $1.12 Million	4,041 Added 35.46%	15,437 $3.59 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $604,944 - $724,640	2,751 Added 31.82%	11,396 $2.73 Million
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $114,282 - $162,941	584 Added 7.24%	8,645 $1.99 Million
Q4 2019 Feb 13, 2020	BUY	$236.45 - $266.82 $197,672 - $223,061	836 Added 11.57%	8,061 $2.19 Million
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $165,556 - $183,865	718 Added 11.03%	7,225 $1.83 Million
Q2 2019 Aug 13, 2019	BUY	$217.4 - $246.08 $153,701 - $173,978	707 Added 12.19%	6,507 $1.64 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $4,327 - $5,211	21 Added 0.36%	5,800 $1.45 Million
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $1.18 Million - $1.49 Million	5,779 New	5,779 $1.3 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $1.02 Million - $1.12 Million	-4,360 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $149,623 - $168,138	719 Added 19.75%	4,360 $1.05 Million
Q1 2018 Sep 10, 2018	BUY	$205.46 - $240.27 $8,012 - $9,370	39 Added 1.08%	3,641 $789,000
Q1 2018 May 14, 2018	BUY	$205.46 - $240.27 $332,023 - $388,276	1,616 Added 81.37%	3,602 $781,000
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $375,354 - $442,163	1,986	1,986 $425,000

Others Institutions Holding BDX

# of Institutions

1,735

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account

Aristotle Atlantic Partners, LLC Becton Dickinson & CO Transaction History